Novel case of androgen receptor‐positive cancer of unknown primary without serum prostate‐specific antigen elevation that became progression free in the long term after primary combined androgen blockade

Author:

Matsuyama Nayuka1,Naiki Taku1ORCID,Naiki‐Ito Aya2,Chaya Ryosuke1,Kawai Tatsuya3,Etani Toshiki1,Nagai Takashi1,Kato Hiroyuki2,Kubota Yasue4,Yasui Takahiro1

Affiliation:

1. Departments of Department of Nephro‐urology Graduate School of Medical Sciences Nagoya City University Nagoya Japan

2. Department of Experimental Pathology and Tumor Biology Graduate School of Medical Sciences Nagoya City University Nagoya Japan

3. Department of Radiology Graduate School of Medical Sciences Nagoya City University Nagoya Japan

4. Department of Clinical Physiology Graduate School of Nursing Nagoya City University Nagoya Aichi Japan

Publisher

Wiley

Subject

Urology

Reference13 articles.

1. Cancer of unknown primary site:20 questions to be answered;Pavlidis N;Ann. Oncol.,2010

2. Occult primary cancer clinical practice guidelines;Ettinger DS;J. Natl Compr. Netw.,2005

3. NCCN Clinical Practice Guidelines in Oncology.Occult Primary (Cancer of unknown primary [CUP] Version 2.2019.

4. Epigenetic profiling to classify of unknown primary: a multicentre, retrospective analysis;Sebastian M;Lancet Oncol.,2016

5. Switching benchmarks in cancer of unknown primary: From autopsy to microarray

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3